Leqembi

Indicated For

Alzheimer's disease

About This Medication

# LEQEMBI Patient Assistance Program: How to Get Lecanemab at Low or No Cost ## About LEQEMBI (Lecanemab-irmb) LEQEMBI is a prescription medication manufactured by Eisai that has been approved by the FDA for specific medical indications. If your healthcare provider has prescribed LEQEMBI but you're concerned about the cost, Eisai offers patient assistance programs to help eligible patients access this medication at reduced or no cost. ## Who Qualifies for the LEQEMBI Patient Assistance Program The LEQEMBI Patient Assistance Program is designed for patients who need financial help paying for their medication[3]. You may be eligible if you meet one of these criteria: - **Uninsured patients**: You have no health insurance coverage - **Insured patients without coverage**: You have health insurance, but your insurance plan does not cover LEQEMBI, and you have been denied coverage after a first-level appeal[3] The program requires that you have a valid prescription for LEQEMBI from your healthcare provider for an FDA-approved indication[3]. ## Income Eligibility The program evaluates patients based on **financial need**[3]. While specific income thresholds are not publicly detailed, the program considers your overall financial situation when determining eligibility. During the enrollment process, you will need to provide documentation of your financial circumstances. The Eisai Patient Support team can discuss your specific situation when you apply. ## Important Insurance Requirements **Who is NOT eligible:** - Patients with Medicare Part B coverage - Patients with Medicaid coverage - Other federal or state-funded health care program beneficiaries[3] If you have commercial insurance that denies coverage for LEQEMBI, you may still qualify for assistance after your insurance company denies your first-level appeal[3]. ## How to Apply: Step-by-Step ### Step 1: Work with Your Healthcare Provider Your healthcare provider plays an important role in the application process. They will need to: - Complete the LEQEMBI Patient Assistance Program enrollment form - Select which program offerings you should be evaluated for - Provide your valid prescription for LEQEMBI[3] ### Step 2: Gather Required Documentation You and your provider will need to submit: - A valid prescription for LEQEMBI - Proof of financial need (such as recent tax returns, pay stubs, or other financial documentation) - If you have insurance: documentation showing that your insurance denied coverage after a first-level appeal[3] - Completed enrollment form with your signature[2] ### Step 3: Submit Your Application You have two options for submitting your enrollment: **Digital Enrollment:** - Visit LEQEMBIEnrollment.com to complete your application online[3] - This is often the fastest method **Fax Submission:** - Your healthcare provider can fax the completed enrollment form to 1-833-770-7017[3] - Include copies of both sides of your insurance cards (if applicable) ### Step 4: Enrollment Verification Once your application is received, the Eisai Patient Support team will begin the enrollment verification process[3]. You can contact them for updates on your application status. ## Timeline and What to Expect While specific processing times are not publicly detailed, the program works to process applications as quickly as possible. Once you are enrolled: - **Enrollment period**: Uninsured patients are enrolled for a rolling 12-month period. Commercially insured patients and federal health care program beneficiaries who qualify are enrolled for the entire calendar year[3] - **Medication delivery**: For LEQEMBI infusions, the program will ship each dose directly to your healthcare provider or infusion center[3] - **Supply limits**: The program ships quantities limited to the number of vials your doctor confirms are needed for a one-month supply[3] ## What Happens If Your Application Is Denied If you are denied enrollment in the Patient Assistance Program, ask the Eisai Patient Support team about alternative options: - **LEQEMBI Copay Assistance Program**: If you have commercial insurance, you may qualify for the copay assistance program instead, which can help reduce your out-of-pocket costs up to $10,000 per calendar year[1][3] - **LEQEMBI Companion Program**: This program offers support services including benefit verification, prior authorization information, and appeal assistance[3] - **Appeal process**: Ask about appealing the denial or reapplying if your circumstances change ## Reauthorization and Ongoing Support Your enrollment in the program requires annual reauthorization[3]. Before your enrollment period ends, the Eisai Patient Support team will contact you about renewing your eligibility. Make sure to keep your contact information current with the program. ## Additional Support Services Beyond medication assistance, Eisai offers the **LEQEMBI Companion Program**, which provides: - A dedicated Patient Navigator to guide you through treatment[3] - Benefit verification and insurance coverage information - Prior authorization support - Appeal information and assistance[3] You can also download the free **LEQEMBI Companion app** for additional support resources[9]. ## Contact Information For questions about the LEQEMBI Patient Assistance Program: - **Phone**: 1-833-453-7362 (1-833-4-LEQEMBI) - **Hours**: Monday–Friday, 8 AM–8 PM ET[1] - **Digital enrollment**: LEQEMBIEnrollment.com[3] - **Fax**: 1-833-770-7017[3] The Eisai Patient Support team can answer your questions about eligibility, help you through the application process, and discuss alternative assistance options if needed. ## Important Disclaimer This guide provides general information about the LEQEMBI Patient Assistance Program based on current program details. Program eligibility, benefits, and requirements may change. Always verify current program terms and conditions with Eisai Patient Support directly. This information is not a guarantee of program enrollment or benefits. Your healthcare provider and the Eisai Patient Support team are your best resources for determining your specific eligibility and next steps.

Program information last verified: March 25, 2026